Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603363's EV-to-FCF is ranked worse than 82.72% of 1192
companies
in the Consumer Packaged Goods industry
Industry Median: 15.77
vs SHSE:603363: 47.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fujian Aonong Biological Technology Grouporp's PE Ratio (TTM) for today is calculated as:
Fujian Aonong Biological Technology Grouporp's share price for today is ¥2.67.
Fujian Aonong Biological Technology Grouporp's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fujian Aonong Biological Technology Grouporp EV-to-FCF Related Terms
Fujian Aonong Biological Technology Grouporp EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Aonong Biological Technology Grouporp EV-to-FCF vs Consumer Packaged Goods Industry
Fujian Aonong Biological Technology Grouporp's current Enterprise Value is ¥9,603 Mil.
Fujian Aonong Biological Technology Grouporp's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a EV-to-FCF of 47.95 as of Jul. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. According to the industry distribution chart, Fujian Aonong Biological Technology Grouporp ranks #986 out of 1192 companies in the Consumer Packaged Goods industry, placing it in the top 82.7%.
Is Fujian Aonong Biological Technology Grouporp's EV-to-FCF too high?
Fujian Aonong Biological Technology Grouporp's current EV-to-FCF is 47.95. The Consumer Packaged Goods industry median EV-to-FCF is 15.77. Fujian Aonong Biological Technology Grouporp's value of 47.95 is 204.1% above this industry median. Based on the distribution chart, Fujian Aonong Biological Technology Grouporp ranks #986 out of 1192 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's EV-to-FCF compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Fujian Aonong Biological Technology Grouporp ranks #986 out of 1192 companies for EV-to-FCF. This places Fujian Aonong Biological Technology Grouporp in the lower half of its industry. The industry median EV-to-FCF is 15.77. Fujian Aonong Biological Technology Grouporp's value of 47.95 is 204.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.77, based on 1,192 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fujian Aonong Biological Technology Grouporp's current EV-to-FCF of 47.95 is 204.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fujian Aonong Biological Technology Grouporp's current EV-to-FCF is 47.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.32, compared to a current price of ¥2.67 — trading 102.3% above its estimated fair value. The current EV-to-FCF is 47.95 and 204.1% above the Consumer Packaged Goods industry median of 15.77. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current EV-to-FCF is 47.95 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued.
The current stock price of ¥2.67 is trading 102.3% above its estimated GF Value™ of ¥1.32.
GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.
Key valuation signals for SHSE:603363:
EV-to-FCF: 47.95
GF Value™: ¥1.32 vs. price of ¥2.67 (102.3% above fair value)
Industry Position: 204.1% above the Consumer Packaged Goods median (#986 of 1192)
No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fujian Aonong Biological Technology Grouporp Business Description
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
31GF Score
Get the complete analysis for SHSE:603363
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603363 has been successfully added to your 
